Search CommunityWalk:


Royer Biomedical

4580 Mack Avenue, Suite E
Frederick, MD 21703, USA

Category: Biotechnology/Biopharmaceutical

Used in the following map:

Maryland Biotech Industry Map

Royer Biomedical, Inc. (RBI) is a mid-stage biotechnology enterprise targeting novel drug delivery systems. RBI has developed proprietary bioabsorbable polymer hydrogel technology for topical and internal controlled release of a wide variety of pharmaceuticals including antibiotics, chemotherapeutic agents, and local anesthetics. The various polymer and calcium-based matrix formulations have extensive patent protection in the US, Europe, Asia, Australia and Mexico. Royer Biomedical is focusing on novel polymer hydrogel based drug delivery systems to provide next generation therapies for diabetes, cancer, and localized infection.

Royer Animal Health LLC is engaged in development of distinct drug delivery matrices for veterinary medicine. The company is a wholly owned subsidiary of Royer Biomedical Inc.

Royer Animal Health offers veterinary practitioners with therapeutic treatments for cancer, infections and general wound management. The company's Matrix IIIâ„¢ technology is based on an inorganic-biopolymer composite. The nature and proportions of the inorganic components and polymers, determine the release profile and the desired erosion rate. The therapeutic advantages based on attributes of the unparalleled Matrix IIIâ„¢ bead technology include: Resorbed by the mechanism of dissolution; Product stability; Unique micro environment; etc.

Royer Animal Health's products include: Matrix IIIâ„¢ cisplatin beads that are effective in the treatment of cancer; and R-Gelâ„¢ antibiotic wound dressing that is proven effective against numerous localized infection. The R-Gelâ„¢ antibiotic wound dressing contains a proprietary formulation of oxidized dextran solution with an adipic dihydrazide cross-linking agent.

Royer Animal Health has partnerships with MWI Veterinary Supply, Inc and Marion duPont Scott Equine Medical Center, Johns Hopkins NIH and Ohio State University.